Page 14 - HLPI 2022 Brochure

Selected Patient Referral Failures (with Leah Fowler), 32 Health Crisis Standards of Care and State Liability Shields, 57(4)

San Diego L. Rev. 924 (2021).
Matrix 1 (2022).
Why a Sustainable Public Health System Needs Community- SETH J. CHANDLER
Based Integrated Health Teams (with Jasmine Singh),
Recent Belmont Health L. J. (2021). Law Foundation Professor of Law

Transforming Data into Information: the Wolfram
Thinking Outside the Silos: Information Sharing in Medical-
Legal Partnerships (with Leah Fowler), 40 J. Legal Med. Language, Wolfram Media, Inc. (forthcoming).
369 (2021).
Faculty Leveraging Community-Based Integrated Health Teams to MICHAEL S. EWER

Health Law LL.M. Director & Distinguished Visiting
Meet the Needs of Vulnerable Populations in Times of Crisis,
30 Annals of Health L. & Life Sci. 133 (2021). Professor
Publications VALERIE GUTMANN KOCH Could Some Reports of Trastuzumab Cardiotoxicity Be a
Surveillance Artifact? (with Swain SM), J Clin Oncol.
2022 Jul 25.
Co-Director, Health Law & Policy Institute
(continued) Assistant Professor of Law BERENICE Final Analysis: Cardiac Safety Study of
Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy
Medical Harm Without Negligence, 91 Fordham L. Rev. __
Followed by Adjuvant Pertuzumab and Trastuzumab in
(forthcoming 2023).
HER2-Positive Early Breast Cancer, (with Dang C, Delaloge
S, Ferrero JM, Colomer R, de la Cruz-Merino L, Werner
Anti-Vaccine Discrimination and Civil Liberties, Issue Brief, TL, Dadswell K, Verrill M, Eiger D, Sarkar S, de Haas
Baker Institute for Public Policy (forthcoming 2022). SL, Restuccia E, Swain SM), Cancers (Basel). 2022 May
24;14(11).
Medical Decision Making and the Previvor, 33(2) J. Clin.
Ethics 141 (2022). Cardiovascular adverse events in oncology trials:
understanding and appreciating the differences between
Norms Reborn: Controversies and Challenges for the Future clinical trial data and real-world reports (with Herson J),
of Reproductive Technologies, 22 Houston J. Health L. & Cardiooncology. 2022 Jul 19; 8(1):13.
Pol’y 1 (2022) (forward to symposium issue).
Cardiac Safety of Osimertinib: A Review of Data (with
Previvors, 49(3) Fla. St. U. L. Rev. 643 (2022). Tekumalla SH, Walding A, Atuah KN), J. Clin. Oncol.
2021; 39:328-337.
Open Notes: Legal and Ethical Issues, The New
Gastroenterologist (2021). Updated results from the international phase III ALTTO
trial (BIG 2-06/Alliance N063D) (with Moreno-Aspitia A,
Preimplantation Genetics: Limitations and Liabilities, in Holmes EM, Jackisch C, de Azambuja E, Boyle F, Hillman
Reproductive Ethics (Julie Chor and Katie Watson, eds.) DW, Korde L, Fumagalli D, Izquierdo MA, McCullough
(2021). AE, Wolff AC, Pritchard KI, Untch M, Guillaume S, Shao
Z, Sim SH, Aziz Z, Demetriou G, Mehta AO, Andersson
M, Toi M, Lang I, Xu B, Smith IE, Barrios CH, Baselga J,
Reciprocity and Liability Protections During the Covid-19 Gelber RD, Piccart-Gebhart M; ALTTO Steer. Com. and
Pandemic (with Diane E. Hoffmann), 51(3) The Hastings
Center Report 5-7 (2021). Invest.), Eur. J. Cancer. 2021;148:287-296.
14